AI assistant
INSMED Inc — Director's Dealing 2019
Apr 11, 2019
30150_dirs_2019-04-11_d369fee3-449f-4d3d-8ada-e0441eac1e6d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2019-04-09
Reporting Person: HAYDEN DONALD J JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-04-09 | Common Stock | M | 6286 | $3.03 | Acquired | 68483 | Direct |
| 2019-04-09 | Common Stock | S | 6286 | $32.99 | Disposed | 62197 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-04-09 | Stock Option (right to buy) | $3.03 | M | 6286 | Disposed | 2021-12-21 | Common Stock (6286) | Direct |
Footnotes
F1: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant.